Your Workout Isn't Working. Your Genes May Explain Why.

ACTN3 encodes alpha-actinin-3, a protein that’s essential for the structure and function of fast-twitch muscle fibers. These are the fibers you recruit for explosive movements like sprinting, jumping, heavy lifting, and high-intensity efforts. Your ACTN3 status determines whether you naturally excel at power-based activities or whether your strength lies in endurance.

Roughly 18% of people with European ancestry carry the X/X null variant, which means they lack functional ACTN3 in their fast-twitch fibers. If you have this variant, your fast-twitch muscle fibers are structurally compromised, reducing your ability to generate explosive power and making traditional strength training less efficient for building raw strength. This doesn’t mean you can’t build strength; it means your body needs a different approach.

People with the X/X null variant typically experience less dramatic gains from heavy strength training, fatigue more quickly during high-intensity efforts, and find their bodies naturally gravitate toward endurance activities. If you’ve always felt slower to generate power than your peers, struggled with heavy compound lifts despite consistent training, or noticed your aerobic capacity is your real strength, your ACTN3 status may explain why.

ADRB2 encodes the beta-2 adrenergic receptor, which sits on the surface of your fat cells and receives signals from catecholamines (epinephrine and norepinephrine) during exercise. When this receptor functions well, your fat cells release stored fat into the bloodstream to fuel your workout. When it doesn’t, your fat cells hold onto their stores, making it far harder to achieve body composition changes despite calorie deficits.

Common variants in ADRB2, particularly the Glu27 and Arg16 variants, are carried by roughly 40% of the population. People with these variants have reduced fat-mobilization capacity during exercise, meaning their fat cells respond weakly to the hormonal signals that trigger fat release, leaving them burning primarily carbohydrate and muscle glycogen during workouts. The result is that cardio and caloric restriction produce slower body composition changes.

If you have an ADRB2 variant, you’ve likely experienced frustratingly slow fat loss despite seemingly adequate calories deficits, plateaus in body composition that don’t budge despite consistent training, or the feeling that your body doesn’t want to part with fat. You might also notice that high-intensity interval training doesn’t deliver the body composition results it does for others, even when total calorie burn is similar.

SOD2 encodes superoxide dismutase 2, an antioxidant enzyme that lives inside your mitochondria and neutralizes free radicals produced during energy production and intense exercise. Intense training naturally increases oxidative stress in muscle tissue. Your SOD2 gene determines whether you clear this stress efficiently or whether it accumulates and damages muscle fibers, extending recovery time.

Approximately 40% of people carry the Ala16 variant homozygously, which impairs the antioxidant activity of SOD2, leaving your muscle cells more vulnerable to oxidative damage during and after exercise. This leads to higher levels of delayed-onset muscle soreness (DOMS), slower tissue repair, and the need for more recovery time between hard sessions.

If you have the SOD2 variant, you’ve likely noticed that you experience worse soreness than your training partners after the same workout, take longer to fully recover even with good sleep and nutrition, feel excessively fatigued after intense training sessions, or find that pushing hard frequently leads to overtraining symptoms that take weeks to resolve.

VDR encodes the vitamin D receptor, a protein that sits on the surface of your muscle cells and responds to active vitamin D. Vitamin D is not just a bone nutrient; it’s essential for muscle protein synthesis, the process by which your muscles repair and grow after training. It also regulates calcium signaling, which triggers muscle contraction and recovery.

Common VDR variants, particularly the BsmI and FokI polymorphisms, occur in 30-50% of the population and reduce your muscle cells’ responsiveness to vitamin D, meaning that even with adequate blood levels of vitamin D, your muscles aren’t accessing it efficiently for repair and protein synthesis. This doesn’t necessarily show up on standard vitamin D tests, which measure circulating levels but not cellular receptor function.

If you have a VDR variant, you may experience slower muscle recovery despite seemingly adequate sleep and nutrition, suboptimal gains in muscle mass despite consistent resistance training, prolonged soreness and stiffness, or the sense that your muscles aren’t adapting as quickly as your peers’ to the same stimulus.

PPARG encodes peroxisome proliferator-activated receptor gamma, a protein that controls metabolic flexibility, your body’s ability to switch between burning fat and carbohydrate based on availability. When this process works smoothly, you burn fat during low-intensity activity and carbohydrate during high-intensity work. When it doesn’t, your metabolism becomes carb-dependent and inefficient at fat burning.

Common PPARG variants reduce your metabolic flexibility and fat oxidation capacity during exercise. People with these variants show reduced fat burning during steady-state cardio, lower efficiency at mobilizing stored energy, and a greater dependence on quick-burning carbohydrate fuels even during low-intensity activity. This means you’re more prone to energy crashes, have fewer options for fat-loss training, and may struggle with sustained energy during longer workouts.

If you have a PPARG variant, you’ve likely experienced bonking or energy crashes during longer training sessions, difficulty sustaining moderate-intensity efforts, the need to refuel frequently even during low-intensity activity, or consistent difficulty achieving lean body composition despite caloric control.

MTHFR encodes methylenetetrahydrofolate reductase, an enzyme that converts dietary folate into the active form your body uses to manage homocysteine levels and produce healthy red blood cells. Homocysteine, an amino acid byproduct, damages blood vessel walls and impairs vascular function. Elevated homocysteine reduces oxygen delivery to your muscles during exercise, directly limiting your aerobic capacity.

Approximately 40% of people with European ancestry carry the MTHFR C677T variant, which reduces the enzyme’s efficiency by 40-70%. This reduced efficiency leads to elevated homocysteine, which impairs vascular function, reduces oxygen delivery during training, and limits your aerobic capacity and exercise tolerance. Your red blood cells also become less efficient at carrying oxygen, compounding the problem.

If you have the MTHFR C677T variant, you’ve likely noticed that your aerobic capacity is lower than expected for your training level, you fatigue faster during sustained effort, experience shortness of breath more easily than peers, or find that endurance training produces smaller gains in VO2max despite consistent work.